Skip to main content
. 2024 Dec 9;9:345. doi: 10.1038/s41392-024-02047-0

Fig. 5.

Fig. 5

The clusters of HER2-low MBC based on plasma ctDNA. a Clustering of HER2-low breast cancer patients using NMF. b Characteristics of the three clusters in oncogenic signaling pathways. c Mutation landscape for three molecular clusters, including cluster 1 (CS1), cluster 2 (CS2), and cluster 3 (CS3), respectively. *P < 0.05